Drugs News and Research

RSS

Researchers find biological weakness in the workings of mutated gene involved in human cancers

NYU Langone Medical Center researchers have found a biological weakness in the workings of the most commonly mutated gene involved in human cancers, known as mutant K-Ras, which they say can be exploited by drug chemotherapies to thwart tumor growth.

10 Feb 2014

New research aims for better monitoring, treatment for chronic kidney disease

Detailed structural and functional 'maps' of the human kidney made using advanced scanning technology are to be developed by scientists at The University of Nottingham.

10 Feb 2014

Obamacare tweaks continue amid complaints

The government will allow consumers who experience life changes, such as a marriage or the birth of a child, to update their plan choices, the administration said. It is also looking at requiring insurers to accept third-party payments, such as those made under the Ryan White CARE Act, to help people with HIV/AIDS pay for expensive drugs. Meanwhile, The Washington Post examines the history of Accenture, the contractor hired to fix healthcare.gov, and finds troubled projects and allegations of ethical lapses.

10 Feb 2014

SMC accepts ILUVIEN for use within NHS Scotland to treat vision impairment

pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Scottish Medicines Consortium (SMC) has accepted ILUVIEN for use within the National Health Service Scotland under a simple patient access scheme.

10 Feb 2014

Mallinckrodt announces commercial launch of PENNSAID

Mallinckrodt today announced the commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.

10 Feb 2014

First Edition: February 10, 2014

Today's headlines include stories about the health law's coverage gap.

10 Feb 2014

NASA signs patent to develop novel biotechnology approaches that could have medical applications

NASA has signed two patent license agreements with GRoK Technologies LLC of Houston to help develop novel biotechnology approaches that could have multiple applications in space and on Earth.

10 Feb 2014

Findings may help physicians choose precise treatments for women with advanced breast cancer

The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already being tested in clinical trials.

10 Feb 2014

New study co-led by scientists sheds light on role of genes, blood lipid levels in cardiovascular health

New genetic evidence strengthens the case that one well-known type of cholesterol is a likely suspect in causing heart disease, but also casts further doubt on the causal role played by another type.

10 Feb 2014

Researchers to highlight biomedical breakthroughs, new discoveries at Biophysical Society Meeting

Ask a question about how the human immune system fights a tropical disease, or how viruses like HIV use genetic tricks to resist drugs, or how plant cells capture light, or how Alzheimer's takes hold in the brain, or how we can better fight diseases like cancer, or why some sperm cells are fertile while others are not, and you may have to narrow your gaze to the nanoscale to find answers.

10 Feb 2014

New study analyses risk factors and mortality among heroin, cocaine consumers admitted to treatment

A new study analyses the risk factors and excess mortality among heroin and cocaine consumers admitted to treatment in Spain. The results reveal that the fatality rate among consumers of both drugs is 14.3 times higher than for the general population, while among those only using cocaine, it is 5.1 times higher.

10 Feb 2014

Immunology professor receives 2014 Szent-Györgyi Prize for progress in cancer research from NFCR

Discovering key elements of immune system T cell biology and applying that knowledge to create a new way to treat cancer has earned Jim Allison, Ph.D., the 2014 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.

10 Feb 2014

Scientists develop new approach to design drugs from genome sequence

In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of principle, they identified a highly potent compound that causes cancer cells to attack themselves and die.

10 Feb 2014

pSivida announces financial results for second quarter 2014

pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced financial results for its second quarter ended December 31, 2013.

10 Feb 2014

Study identifies seven new genetic regions associated with type 2 diabetes

Seven new genetic regions associated with type 2 diabetes have been identified in the largest study to date of the genetic basis of the disease.

9 Feb 2014

Study points to molecular pathway to treat recurring, deadly malignancies

Analyzing the genomes of twin 3-year-old sisters – one healthy and one with aggressive leukemia – led an international team of researchers to identify a novel molecular target that could become a way to treat recurring and deadly malignancies.

9 Feb 2014

Researchers shed light on role of genes and blood lipid levels in cardiovascular health

New genetic evidence strengthens the case that one well-known type of cholesterol is a likely suspect in causing heart disease, but also casts further doubt on the causal role played by another type. The findings may guide the search for improved treatments for heart disease.

9 Feb 2014

Drugs News and Research

Researchers find biological weakness in the workings of mutated gene involved in human cancers

New research aims for better monitoring, treatment for chronic kidney disease

Obamacare tweaks continue amid complaints

SMC accepts ILUVIEN for use within NHS Scotland to treat vision impairment

Mallinckrodt announces commercial launch of PENNSAID

First Edition: February 10, 2014

NASA signs patent to develop novel biotechnology approaches that could have medical applications

Findings may help physicians choose precise treatments for women with advanced breast cancer

New study co-led by scientists sheds light on role of genes, blood lipid levels in cardiovascular health

Researchers to highlight biomedical breakthroughs, new discoveries at Biophysical Society Meeting

New study analyses risk factors and mortality among heroin, cocaine consumers admitted to treatment

Immunology professor receives 2014 Szent-Györgyi Prize for progress in cancer research from NFCR

Scientists develop new approach to design drugs from genome sequence

pSivida announces financial results for second quarter 2014

Study identifies seven new genetic regions associated with type 2 diabetes

Study points to molecular pathway to treat recurring, deadly malignancies

Researchers shed light on role of genes and blood lipid levels in cardiovascular health

New method to build tiny degradable 'medicine factories' inside the body

Disorganisation, verbal memory help shape QoL in schizophrenia

Loyola University toxicologist to talk about rise seen in heroin overdoses in recent years

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News